VIDEO ACCESS:
MAYO CLINIC CARE NETWORK:  You are being directed here from the video housed in the Care Network portal.

RELEASE:  February 3, 2020
EXPIRATION:  December 31, 2021 (Credit is not available after this expiration date.)

LEARNING OBJECTIVES:

  • Review new and novel approaches to treatment of dyslipidemia including RNA silencing.
  • Discuss the pros and cons of using therapies which have infrequent dosing.
  • Debate the role of statin therapy in primary prevention vs new techniques with greater potential adherence.

 

ACCREDITATION

In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


CREDIT STATEMENT

AMA
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of .75 AMA PRA Category 1 CreditsTM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INSTRUCTIONS:

  • Click the Start button below.
  • Participate in the quiz.  Participants must pass by a minimum of 80%, 1 re-take is allowed.  Quizzes have between 2-5 questions.
  • Complete the evaluation and click through to the end to ensure credits post to your transcript.  

TRANSCRIPT:
This credit will appear on your Transcript for permanent record.  To access your transcript, visit My Account, My Courses, RSS Transcript.

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry:

Panithaya Chareonthaitawee, M.D.
Consultant - Bioclinica, Medtrace, GE Healthcare; Royalties - UptoDate

Stephen L. Kopecky, M.D.
Consultant - Prime Therapeutics; Grant/Research Support - True Health

Speaker: R. Scott Wright, M.D.
Consultant - The Medicines Company, Boehringer-Ingelheim, CSL-Behring

No relevant financial relationship(s) with industry:

Julie McAdams, M.B.A.
John Bois, M.D.
Rick Nishimura, M.D.
Gayle L. Flo, APRN, C.N.P. 
Andrea Hare
Michael W. Cullen, M.D.
Abhiram Prasad, M.D.
Jane Linderbaum, APRN, C.N.P.
Courtney E. Bennett, D.O.
William R. Miranda, M.D.
Suraj Kapa, M.D.

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
The Medicines Company - Inclisiran

QUESTIONS?
Contact:  cme@mayo.edu

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Presenter: 
R. Scott Wright, M.D.
Support location: 
Minnesota

Please login or register to take this course.
Support location: 
Minnesota